-
1
-
2
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Published 2024-11-01Subjects: Get full text
Article -
3
-
4
Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients
Published 2025-01-01Subjects: “…PD-1/PD-L1 inhibitors…”
Get full text
Article -
5
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
Published 2024-08-01Subjects: Get full text
Article -
6
-
7